Effect of Aquatic High Intensity Resistive Training on Patients With Chronic Heart Failure
PURPOSE: to evaluate effect of aquatic high intensity resistive training on cardiac function and exercise capacity in patients with chronic heart failure. BACKGROUND: Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of \>37.7 million individuals globally. HF is a shared chronic p
| Condition(s) | Heart Failure |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | PURPOSE: to evaluate effect of aquatic high intensity resistive training on cardiac function and exercise capacity in patients with chronic heart failure. BACKGROUND: Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of \>37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many etiologies, and patients with HF experience numerous symptoms that affect their quality of life, including dyspnea, fatigue, poor exercise tolerance, and fluid retention. |
| Who can participate | Inclusion Criteria: Age ranges from 45 to 60 years old. Have chronic heart failure (NYHA class I to III). * Left ventricular ejection fraction (LVEF) \> 50% * clinically stable with optimal pharmacological therapy in greater than three months * All patients didn't participate in any rehabilitation programs prior to the study. Exclusion Criteria: Signs of acute heart failure, unstable angina, or severe arrhythmia three months prior to enrolment in the study. Pacemakers. recently diagnosed acute coronary syndrome or a recent coronary intervention or both renal insufficiency (estimated glomerular filtration rate \< 30 mL/min) liver abnormalities uncontrolled hypertension moderate-to-severe valvular disease uncompensated heart failure patients Chronic lung disease. Other disorders counteractin |
| Ages | 45 Years to 60 Years |
| Sex | All |
| Lead sponsor | Cairo University |
| Locations | Cairo, Dokki, Egypt |
| Start date | 2024-03-05 |
| NCT ID | NCT06297707 |
| Official listing | https://clinicaltrials.gov/study/NCT06297707 |